Skip to main content

and
  1. No Access

    Article

    Tumour prevention and rejection with recombinant vaccinia

    Tumour-specific antigens (TSA; ref. 1) have been exploited in the diagnosis2 and imaging3 of human cancer and anti-TSA antibodies have therapeutic potential4. Vaccination with TSA5–8 or anti-idiotypic (TSA) anti...

    R. Lathe, M. P. Kieny, P. Gerlinger, P. Clertant, I. Guizani, F. Cuzin in Nature (1987)

  2. No Access

    Article

    Oral vaccination of the fox against rabies using a live recombinant vaccinia virus

    Rabies, a viral disease affecting all warm-blooded animals, is prevalent in most parts of the world1, where it propagates amongst wild animals, particularly the fox and dog. The public health and economic consequ...

    J. Blancou, M. P. Kieny, R. Lathe, J. P. Lecocq, P. P. Pastore, J. P. Soulebot in Nature (1986)

  3. No Access

    Article

    Novel DNA sequence representations (reply)

    R. LATHE, R. FINDLAY in Nature (1985)

  4. No Access

    Article

    Expression of rabies virus glycoprotein from a recombinant vaccinia virus

    Rabies is one of the oldest diseases known to man, but its successful control has remained elusive. Although effective vaccines of tissue culture origin against rabies do exist1, such preparations are expensive. ...

    M. P. Kieny, R. Lathe, R. Drillien, D. Spehner, S. Skory, D. Schmitt, T. Wiktor in Nature (1984)

  5. Article

    Machine-readable DNA sequences

    R. LATHE, R. FINDLAY in Nature (1984)